๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Weekly Docetaxel and Epirubicin in Treatment of Advanced Hormone-Refractory Prostate Cancer

โœ Scribed by Roberto Petrioli; Loretta Paolelli; Edoardo Francini; Antonio Manganelli; Francesco Salvestrini; Guido Francini

Book ID
116947102
Publisher
Elsevier Science
Year
2007
Tongue
English
Weight
81 KB
Volume
69
Category
Article
ISSN
0090-4295

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Suramin in combination with weekly epiru
Suramin in combination with weekly epirubicin for patients with advanced hormone-refractory prostate carcinoma
โœ Alfredo Falcone; Andrea Antonuzzo; Romano Danesi; Giacomo Allegrini; Lencioni Mo ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 97 KB ๐Ÿ‘ 2 views

## BACKGROUND. Suramin and epirubicin are both active agents in the treatment of patients with hormone-refractory advanced prostate carcinoma, with demonstrated antitumor synergism in vitro on human prostate carcinoma cells and different dose-limiting toxicities. The authors conducted this Phase I